Stewart Sharp
Hematology & Oncology · Bismarck, NDNPI 1235124934
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.0% of the total across 115 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations.
Across 115 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$417
- Merck$255
- Genentech USA, Inc.$203
- E.r. Squibb & Sons, L.L.C.$201
- AstraZeneca$200
- Sanofi$98
- plus $639 from 20 others
What the payments were for
- Food & beverage$1,91495%
- Education$1005%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 16 | $417 |
| Merck | 16 | $255 |
| Genentech USA, Inc. | 12 | $203 |
| E.r. Squibb & Sons, L.L.C. | 14 | $201 |
| AstraZeneca(2 entities) | 12 | $200 |
| Sanofi | 5 | $98 |
| Lilly USA, LLC | 4 | $71 |
| Gilead | 4 | $62 |
| Pfizer | 5 | $61 |
| Johnson & Johnson | 3 | $52 |
| Ipsen Biopharmaceuticals, Inc | 2 | $46 |
| Bristol Myers Squibb | 2 | $39 |
| Seagen Inc. | 3 | $37 |
| Eisai Inc. | 2 | $36 |
| EMD Serono, Inc. | 2 | $30 |
| Novartis | 2 | $29 |
| Sandoz | 1 | $23 |
| Astellas Pharma US Inc | 1 | $20 |
| Clovis Oncology, Inc. | 2 | $20 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Exelixis Inc. | 1 | $16 |
| GSK | 1 | $16 |
| Incyte Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,014 in reported general payments places this provider in the 75th percentile of 35 hematology & oncology providers in North Dakota.
Other hematology & oncology in Bismarck
- Peter KurnialiBismarck$8K
- Matthew McGeeBismarck$3K
- Thandiwe GrayBismarck$2K
- Sagar RakshitBismarck$2K
- John ReynoldsBismarck$2K
- Alexander JohnsonBismarck$1K
- Edward WosBismarck$1K
- Aaron LuebkeBismarck$829
- David Oladele-BankoleBismarck$16
- Baruti SerabeBismarck$14
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.